SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Evogene Q3 Revenue Falls After Bayer Agreement Ends

Evogene reported a sharp decline in third-quarter revenue after its agreement with Bayer ended.

EVGN

Related stories